Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Abemaciclib methanesulfonate (LY2835219) is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 30.00 | |
5 mg | In stock | $ 50.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 86.00 | |
50 mg | In stock | $ 98.00 | |
100 mg | In stock | $ 126.00 | |
200 mg | In stock | $ 157.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 67.00 |
Description | Abemaciclib methanesulfonate (LY2835219) is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM). |
Targets&IC50 | CDK4:2 nM, CDK6:10 nM |
In vitro | In subcutaneous and intracranial glioma models (U87 mg), MsOH treatment results in LY2835219 inhibiting tumor growth in a dose-dependent manner. |
In vivo | In retinoblastoma, LY2835219 inhibits cancer cell growth by specifically targeting and inhibiting CDK4 and CDK6, leading to cell cycle arrest at the G1 phase and suppression of DNA synthesis. |
Kinase Assay | Cells (5 × 103) are plated in 96 well plates. Cells are treated the next day for 24 to 48 hours and then assessed for caspase-3 activity by Caspase-Glo-3/7 Assay, as per manufacturer's instructions and a luminescence plate reader. |
Cell Research | LY2835219 is dissolved in DMSO to a 10 mM concentration.? Cells are seeded in a 96-well plate, allowed to adhere overnight, and treated with DMSO control (0.1% v/v) or the indicated compounds for 72 h. Cell viability and proliferation are determined using a Cell Counting Kit according to the manufacturer's instructions. The interaction between LY2835219 and mTOR inhibitor is determined using CompuSyn. Combination index (CI) values of 1 indicates and additive drug interaction, whereas a CI of < 1 is synergistic and a CI of > 1 is antagonistic. |
Synonyms | abemaciclib mesylate, LY2835219, LY2835219 mesylate, LY2835219 (methanesulfonate) |
Molecular Weight | 602.7 |
Formula | C27H32F2N8·CH4O3S |
CAS No. | 1231930-82-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 45mg/mL (74.7mM)
DMSO: 77 mg/mL (127.8 mM)
Ethanol: 23 mg/mL (38.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Abemaciclib methanesulfonate 1231930-82-7 Cell Cycle/Checkpoint CDK inhibit Inhibitor abemaciclib mesylate LY2835219 Cyclin dependent kinase LY2835219 mesylate LY 2835219 Abemaciclib LY2835219 Mesylate LY-2835219 LY-2835219 Mesylate LY2835219 (methanesulfonate) methanesulfonate LY 2835219 Mesylate abemaciclib Mesylate inhibitor